Substituted pyrido [3,2-e]pyrazine compound

PK139928AUndetermined Publication Date: 2009-01-17ARZNEIMITTELWERK DRESDEN GMBH
0 Cites 0 Cited by

Patent Information

Application Number
PK200700575
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-17
Patent Text Reader

Abstract

The invention relates to pyrido[3,2e]pyrazines of formula II to process for preparing it, to pharmaceutical preparation which comprise this compound which is inhibitor of phosphodiesterase 10, as active compound for treating diseases of mammals including a human which can be influenced by using the compound according to the invention to inhibit phosphodiesterease 10 activity in the central nervous system. More particularly, the invention relates to the treatment of neurologic and psychiatric disorders, for example psychosis and disorders comprising cognitive deficits as symptoms.
Need to check novelty before this filing date? Find Prior Art